TELA Bio (TELA) Cash from Operations Growth (3y) (2021 - 2026)
TELA Bio (TELA) Cash from Operations Growth (3y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 27.41% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 22.38% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 1.51% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 30.85% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 168.71% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 12.26% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 65.19% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 43.79% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 9.30% |
| 10 | TELA Bio | 36.75 Mn | 6.32 Mn | 13.94 Mn | 5.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 5.92% |
| Mar 31, 2026 | 1.18% |
| Dec 31, 2025 | 23.74% |
| Sep 30, 2025 | 9.24% |
| Jun 30, 2025 | 12.22% |
| Mar 31, 2025 | 2.31% |
| Dec 31, 2024 | 7.73% |
| Sep 30, 2024 | -10.65% |
| Jun 30, 2024 | -23.86% |
| Mar 31, 2024 | -18.77% |
| Dec 31, 2023 | -15.87% |
| Sep 30, 2023 | -23.60% |
| Jun 30, 2023 | -21.02% |
| Mar 31, 2023 | -16.57% |
| Dec 31, 2022 | -15.20% |
| Sep 30, 2022 | -12.61% |
| Jun 30, 2022 | -30.94% |
| Mar 31, 2022 | -10.28% |
| Dec 31, 2021 | -18.49% |